Redigerer
Alzheimers sykdom
(avsnitt)
Hopp til navigering
Hopp til søk
Advarsel:
Du er ikke innlogget. IP-adressen din vil bli vist offentlig om du redigerer. Hvis du
logger inn
eller
oppretter en konto
vil redigeringene dine tilskrives brukernavnet ditt, og du vil få flere andre fordeler.
Antispamsjekk.
Ikke
fyll inn dette feltet!
==Referanser== <references> <ref name="abella2009">{{cite journal |author = Abella HA |title = Report from SNM: PET imaging of brain chemistry bolsters characterization of dementias |journal = Diagnostic Imaging |date = 16. juni 2009 |url = http://www.diagnosticimaging.com/imaging-trends-advances/cardiovascular-imaging/article/113619/1423022 }}{{død lenke|dato=januar 2018 |bot=InternetArchiveBot }}</ref> <ref name="alzheimers.org"> {{cite web | title=What is Alzheimer's disease? | url=http://www.alzheimers.org.uk/site/scripts/documents_info.php?documentID=100 | publisher=Alzheimers.org.uk | year=2007 | month=august | accessdate=2008-02-21 }}</ref> <ref name="alzres"> {{cite web |title = Alzheimer's diagnosis of AD |url = http://www.alzheimers-research.org.uk/info/diagnosis/ |publisher = Alzheimer's Research Trust |accessdate = 2008-02-29 |url-status = død |archiveurl = https://web.archive.org/web/20071022154220/http://alzheimers-research.org.uk/info/diagnosis/ |archivedate = 2007-10-22 }}</ref> <ref name="Brookmeyer2007">2006 prevalence estimate: *{{cite journal |author = Brookmeyer R, Johnson E, Ziegler-Graham K, MH Arrighi |title = Forecasting the global burden of Alzheimer's disease |journal = Alzheimer's and Dementia |volume = 3 |issue = 3 |pages = 186–91 |year = 2007 |month = juli |doi = 10.1016/j.jalz.2007.04.381 |url = http://works.bepress.com/cgi/viewcontent.cgi?article=1022&context=rbrookmeyer |accessdate = 2008-06-18 |pmid = 19595937 |last1 = Brookmeyer |first1 = R |last2 = Johnson |first2 = E |last3 = Ziegler-Graham |first3 = K |last4 = Arrighi |first4 = HM |archiveurl = https://web.archive.org/web/20081207025403/http://works.bepress.com/cgi/viewcontent.cgi?article=1022&context=rbrookmeyer |url-status = dead }} {{Kilde www |url=http://works.bepress.com/cgi/viewcontent.cgi?article=1022&context=rbrookmeyer |tittel=Arkivert kopi |besøksdato=2010-11-21 |arkiv-dato=2008-12-07 |arkiv-url=https://web.archive.org/web/20081207025403/http://works.bepress.com/cgi/viewcontent.cgi?article=1022&context=rbrookmeyer |url-status=unfit }} *{{cite journal |url = http://un.org/esa/population/publications/wpp2006/WPP2006_Highlights_rev.pdf |format = PDF |accessdate = 2008-08-27 |year = 2007 |title = World population prospects: the 2006 revision, highlights |publisher = Population Division, Department of Economic and Social Affairs, United Nations |version = Working Paper No. ESA/P/WP.202 |archiveurl = https://web.archive.org/web/20080819191533/http://www.un.org/esa/population/publications/wpp2006/WPP2006_Highlights_rev.pdf |url-status = dead }} {{Kilde www |url=http://un.org/esa/population/publications/wpp2006/WPP2006_Highlights_rev.pdf |tittel=Arkivert kopi |besøksdato=2010-11-21 |arkiv-dato=2008-08-19 |arkiv-url=https://web.archive.org/web/20080819191533/http://un.org/esa/population/publications/wpp2006/WPP2006_Highlights_rev.pdf |url-status=yes }}</ref> <ref name="demeyer">{{cite journal |author=De Meyer G, Shapiro F, Vanderstichele H, Vanmechelen E, Engelborghs S, De Deyn PP, Coart E, Hansson O, Minthon L, Zetterberg H, Blennow K, Shaw L, Trojanowski JQ |title=Diagnosis-Independent Alzheimer Disease Biomarker Signature in Cognitively Normal Elderly People |journal=Arch Neurol. |volume=67 |issue=8 |pages=949–56 |year=2010 |month=august |pmid=20697045 |doi=10.1001/archneurol.2010.179 }}</ref> <ref name="Heneka">Heneka MT, Nadrigny F, Regen T, Martinez-Hernandez A, Dumitrescu-Ozimek L, Terwel D, Jardanhazi-Kurutz D, Walter J, Kirchhoff F, Hanisch UK, Kummer MP. (2010). [http://www.pnas.org.libproxy.ucl.ac.uk/content/107/13/6058.full.pdf Locus ceruleus controls Alzheimer's disease pathology by modulating microglial functions through norepinephrine.] Proc Natl Acad Sci USA A. 107:6058-6063{{doi|10.1073/pnas.0909586107}} PMID 20231476</ref> <ref name="isbn0-89004-225-X">{{cite book |author=Katzman Robert, Terry Robert D, Bick Katherine L (editors) |title=Alzheimer's disease: senile dementia and related disorders |publisher=Raven Press |location=New York |year=1978 |page=595 |isbn=0-89004-225-X |oclc= }}</ref> <ref name="isbn1-4325-0833-4">{{cite book |author=Kraepelin Emil, Diefendorf A. Ross (translated by) |title=Clinical Psychiatry: A Textbook For Students And Physicians (Reprint) |url=https://archive.org/details/clinicalpsychiat0000emil |publisher=Kessinger Publishing |date=2007-01-17 |page=[https://archive.org/details/clinicalpsychiat0000emil/page/568 568] |isbn=1-4325-0833-4 |oclc= }}</ref> <ref name="isbn9789241563369">{{cite book | last = World Health Organization | title = Neurological Disorders: Public Health Challenges | publisher = World Health Organization | year = 2006 | location = Switzerland | pages = 204–207 | url = http://www.who.int/mental_health/neurology/neurodiso/en/index.html | isbn = 978-92-4-156336-9 }}</ref> <ref name="metlife.com">{{cite web |url = http://www.metlife.com/WPSAssets/14050063731156260663V1FAlzheimerCaregivingExperience.pdf |title = The MetLife study of Alzheimer's disease: The caregiving experience |month = august |year = 2006 |archivedate = 2008-06-25 |archiveurl = https://web.archive.org/web/20080625071754/http://www.metlife.com/WPSAssets/14050063731156260663V1FAlzheimerCaregivingExperience.pdf |publisher = MetLife Mature Market Institute |format = PDF |accessdate = 2008-02-12 |url-status = død }}</ref> <ref name="nihstages">{{cite web |title = Understanding stages and symptoms of Alzheimer's disease |url = http://www.nia.nih.gov/Alzheimers/Publications/stages.htm |publisher = National Institute on Aging |date = 2007-10-26 |accessdate = 2008-02-21 |url-status = død |archiveurl = https://web.archive.org/web/20080516213955/http://www.nia.nih.gov/Alzheimers/Publications/stages.htm |archivedate = 2008-05-16 }}</ref> <ref name="Nikolaev">{{cite journal | first= Anatoly | last= Nikolaev | coauthors= Todd McLaughlin, Dennis O'Leary, [[Marc Tessier-Lavigne]] | date= 19. februar 2009 | title= N-APP binds DR6 to cause axon pruning and neuron death via distinct caspases | journal= Nature | volume= 457 | issue= 7232 | pages= 981–989 | issn= 0028-0836 | pmid= 19225519 | pmc= 2677572 | doi= 10.1038/nature07767 | accessdate= 31. mai 2009 }} </ref> <ref name="nlm6040">{{cite web |url=http://www.nlm.nih.gov/medlineplus/druginfo/meds/a604006.html |title=Memantine |accessdate=2010-02-03 |date=2004-01-04 |publisher= US National Library of Medicine (Medline) }}</ref> <ref name="pmid1300219"> {{cite journal |author=Carlesimo GA, Oscar-Berman M |title=Memory deficits in Alzheimer's patients: a comprehensive review |journal=Neuropsychol Rev |volume=3 |issue=2 |pages=119–69 |year=1992 |month=juni |pmid=1300219 |doi=10.1007/BF01108841 }}</ref> <ref name="pmid1512391">{{cite journal |author=Tombaugh TN, McIntyre NJ |title=The mini-mental state examination: a comprehensive review |journal=J Am Geriatr Soc |volume=40 |issue=9 |pages=922–35 |year=1992 |month=september |pmid=1512391 }}</ref> <ref name="pmid1669718"> {{cite journal |author=Goedert M, Spillantini MG, Crowther RA |title=Tau proteins and neurofibrillary degeneration |journal=Brain Pathol |volume=1 |issue=4 |pages=279–86 |year=1991 |month=juli |pmid=1669718 |doi=10.1111/j.1750-3639.1991.tb00671.x }}</ref> <ref name="pmid1763432"> {{cite journal |author=Hardy J, Allsop D |title=Amyloid deposition as the central event in the aetiology of Alzheimer's disease |journal=Trends Pharmacol. Sci. |volume=12 |issue=10 |pages=383–88 |year=1991 |month=oktober |pmid=1763432 |doi=10.1016/0165-6147(91)90609-V }}</ref> <ref name="pmid1856925">{{cite journal |author=Taler V, Phillips NA |title=Language performance in Alzheimer's disease and mild cognitive impairment: a comparative review |journal= J Clin Exp Neuropsychol |volume=30 |issue=5 |pages=501–56 |year=2008 |month=juli |pmid=1856925 |doi=10.1080/13803390701550128 }}</ref> <ref name="pmid 19501936">{{cite journal |author=Rupsingh R, Borrie M, Smith M, Wells JL, Bartha R |title=Reduced hippocampal glutamate in Alzheimer disease |journal=[[Neurobiol Aging]] |year=2009 |month=juni |pmid=19501936 |doi=10.1016/j.neurobiolaging.2009.05.002 }}</ref> <ref name="pmid2218531">{{cite journal |author=Yankner BA, Duffy LK, Kirschner DA |title=Neurotrophic and neurotoxic effects of amyloid beta protein: reversal by tachykinin neuropeptides |url=https://archive.org/details/sim_science_1990-10-12_250_4978/page/n129 |journal=Science (journal) |volume=250 |issue=4978 |pages=279–82 |year=1990 |month=oktober |pmid=2218531 |doi=10.1126/science.2218531 }}</ref> <ref name="pmid2241719">{{cite journal |author=Brodaty H, Hadzi-Pavlovic D |title=Psychosocial effects on carers of living with persons with dementia |journal=Aust N Z J Psychiatry |volume=24 |issue=3 |pages=351–61 |year=1990 |month=september |pmid=2241719 |doi=10.3109/00048679009077702 }}</ref> <ref name="pmid3531918">{{cite journal |author=Amaducci LA, Rocca WA, Schoenberg BS |title=Origin of the distinction between Alzheimer's disease and senile dementia: how history can clarify nosology |journal=Neurology |volume=36 |issue=11 |pages=1497–9 |year=1986 |month=november |pmid=3531918 }}</ref> <ref name="pmid3776457">{{cite journal |author=Mölsä PK, Marttila RJ, Rinne UK |title=Survival and cause of death in Alzheimer's disease and multi-infarct dementia |journal=Acta Neurol Scand |volume=74 |issue=2 |pages=103–7 |year=1986 |month=august |pmid=3776457 |accessdate=2008-08-04 |doi=10.1111/j.1600-0404.1986.tb04634.x }}</ref> <ref name="pmid6610841">{{cite journal |author=McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM |title=Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease |url=https://archive.org/details/sim_neurology_1984-07_34_7/page/939 |journal=Neurology |volume=34 |issue=7 |pages=939–44 |year=1984 |month=juli |pmid=6610841 }}</ref> <ref name="pmid7566000"> {{cite journal |author=Polvikoski T, Sulkava R, Haltia M, ''et al.'' |title=Apolipoprotein E, dementia, and cortical deposition of beta-amyloid protein |journal=N Engl J Med |volume=333 |issue=19 |pages=1242–47 |year=1995 |month=november |pmid=7566000 |doi=10.1056/NEJM199511093331902 }}</ref> <ref name="pmid7771442">{{cite journal |author=Kukull WA, Larson EB, Bowen JD, ''et al.'' |title=Solvent exposure as a risk factor for Alzheimer's disease: a case-control study |journal=Am J Epidemiol |volume=141 |issue=11 |pages=1059–71; discussion 1072–9 |year=1995 |month=juni |pmid=7771442 }}</ref> <ref name="pmid7792352">{{cite journal |author=Jagger C, Clarke M, Stone A |title=Predictors of survival with Alzheimer's disease: a community-based study |url=https://archive.org/details/sim_psychological-medicine_1995-01_25_1/page/171 |journal=Psychol Med |volume=25 |issue=1 |pages=171–7 |year=1995 |month=januar |pmid=7792352 |doi=10.1017/S0033291700028191 }}</ref> <ref name="pmid7793228">{{cite journal |author=Mölsä PK, Marttila RJ, Rinne UK |title=Long-term survival and predictors of mortality in Alzheimer's disease and multi-infarct dementia |journal=ActaNeurol Scand |volume=91 |issue=3 |pages=159–64 |year=1995 |month=mars |pmid=7793228 }}</ref> <ref name="pmid7806732">{{cite journal |author=Gold DP, Reis MF, Markiewicz D, Andres D |title=When home caregiving ends: a longitudinal study of outcomes for caregivers of relatives with dementia |url=https://archive.org/details/sim_journal-of-the-american-geriatrics-society_1995-01_43_1/page/10 |journal=J Am Geriatr Soc |volume=43 |issue=1 |pages=10–6 |year=1995 |month=januar |pmid=7806732 }}</ref> <ref name="pmid7967534">{{cite journal |author=Frank EM |title=Effect of Alzheimer's disease on communication function |url=https://archive.org/details/sim_journal-of-the-south-carolina-medical-association_1994-09_90_9/page/417 |journal=J S C Med Assoc |volume=90 |issue=9 |pages=417–23 |year=1994 |month=september |pmid=7967534 }}</ref> <ref name="pmid7986174">{{cite journal |author=Blacker D, Albert MS, Bassett SS, Go RC, Harrell LE, Folstein MF |title=Reliability and validity of NINCDS-ADRDA criteria for Alzheimer's disease. The National Institute of Mental Health Genetics Initiative |journal=Arch. Neurol. |volume=51 |issue=12 |pages=1198–204 |year=1994 |month=desember |pmid=7986174 }}</ref> <ref name="pmid8038565">{{cite journal |author=Bouras C, Hof PR, Giannakopoulos P, Michel JP, Morrison JH |title=Regional distribution of neurofibrillary tangles and senile plaques in the cerebral cortex of elderly patients: a quantitative evaluation of a one-year autopsy population from a geriatric hospital |journal=Cereb. Cortex |volume=4 |issue=2 |pages=138–50 |year=1994 |pmid=8038565 |doi=10.1093/cercor/4.2.138 }}</ref> <ref name="pmid8446617">{{cite journal |author=Strittmatter WJ, Saunders AM, Schmechel D, ''et al.'' |title=Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease |journal=Proc. Natl. Acad. Sci. USA |volume=90 |issue=5 |pages=1977–81 |year=1993 |month=mars |pmid=8446617 |pmc=46003 |doi=10.1073/pnas.90.5.1977 }}</ref> <ref name="pmid8534419">{{cite journal |author=Geula C, Mesulam MM |title=Cholinesterases and the pathology of Alzheimer disease |journal=[[Alzheimer Dis Assoc Disord]] |volume=9 Suppl 2 |pages=23–28 |year=1995 |pmid=8534419 }}</ref> <ref name="pmid8752526">{{cite journal |author=Ito N |title=[Clinical aspects of dementia] |language=japansk |journal=Hokkaido Igaku Zasshi |volume=71 |issue=3 |pages=315–20 |year=1996 |month=mai |pmid=8752526 }}</ref> <ref name="pmid8757016">{{cite journal |author=Bowen JD, Malter AD, Sheppard L, ''et al.'' |title=Predictors of mortality in patients diagnosed with probable Alzheimer's disease |url=https://archive.org/details/sim_neurology_1996-08_47_2/page/433 |journal=Neurology |volume=47 |issue=2 |pages=433–9 |year=1996 |month=august |pmid=8757016 }}</ref> <ref name="pmid8821346"> {{cite journal |author=Jelicic M, Bonebakker AE, Bonke B |title=Implicit memory performance of patients with Alzheimer's disease: a brief review |journal=International Psychogeriatrics |volume=7 |issue=3 |pages=385–392 |year=1995 |pmid=8821346 | doi = 10.1017/S1041610295002134 }}</ref> <ref name="pmid8938131">{{cite journal |author=Borchelt DR, Thinakaran G, Eckman CB, ''et al.'' |title=Familial Alzheimer's disease-linked presenilin 1 variants elevate Aβ1-42/1-40 ratio in vitro and in vivo. |journal=Neuron |volume=17 |issue=5 |pages=1005–13 |year=1996 |month=november |pmid=8938131 |doi=10.1016/S0896-6273(00)80230-5 |last12=Wang |first12=R |last13=Seeger |first13=M |last14=Levey |first14=AI |last15=Gandy |first15=SE |last16=Copeland |first16=NG |last17=Jenkins |first17=NA |last18=Price |first18=DL |last19=Younkin |first19=SG |last20=Sisodia |first20=SS }}</ref> <ref name="pmid9115023">{{cite journal |author=Martyn CN, Coggon DN, Inskip H, Lacey RF, Young WF |title=Aluminum concentrations in drinking water and risk of Alzheimer's disease |journal=Epidemiology |volume=8 |issue=3 |pages=281–6 |year=1997 |month=mai |pmid=9115023 |doi=10.1097/00001648-199705000-00009 }}</ref> <ref name="pmid9153154">{{cite journal |author=Geldmacher DS, Whitehouse PJ |title=Differential diagnosis of Alzheimer's disease |journal=Neurology |volume=48 |issue=5 Suppl 6 |pages=S2–9 |year=1997 |month=mai |pmid=9153154 }}</ref> <ref name="pmid9543467">{{cite journal |author=Meek PD, McKeithan K, Schumock GT |title=Economic considerations in Alzheimer's disease |journal=Pharmacotherapy |volume=18 |issue=2 Pt 2 |pages=68–73; discussion 79–82 |year=1998 |pmid=9543467 }}</ref> <ref name="pmid9646153">{{cite journal |author=Donaldson C, Tarrier N, Burns A |title=Determinants of carer stress in Alzheimer's disease |url=https://archive.org/details/sim_international-journal-of-geriatric-psychiatry_1998-04_13_4/page/248 |journal=Int J Geriatr Psychiatry |volume=13 |issue=4 |pages=248–56 |year=1998 |month=april |pmid=9646153 |doi=10.1002/(SICI)1099-1166(199804)13:4<248::AID-GPS770>3.0.CO;2-0 }}</ref> <ref name="pmid9702682">{{cite journal |author=Boller F, Forbes MM |title=History of dementia and dementia in history: an overview |url=https://archive.org/details/sim_journal-of-the-neurological-sciences_1998-06-30_158_2/page/n9 |journal=J. Neurol. Sci. |volume=158 |issue=2 |pages=125–33 |year=1998 |month=juni |pmid=9702682 |doi=10.1016/S0022-510X(98)00128-2 }}</ref> <ref name="pmid9861186">{{cite journal |author=Graves AB, Rosner D, Echeverria D, Mortimer JA, Larson EB |title=Occupational exposures to solvents and aluminium and estimated risk of Alzheimer's disease |journal=Occup Environ Med |volume=55 |issue=9 |pages=627–33 |year=1998 |month=september |pmid=9861186 |pmc=1757634 |doi=10.1136/oem.55.9.627 }}</ref> <ref name="pmid9987708">{{cite journal |author=Pasquier F |title=Early diagnosis of dementia: neuropsychology |journal=J. Neurol. |volume=246 |issue=1 |pages=6–15 |year=1999 |month=januar |pmid=9987708 |doi=10.1007/s004150050299 }}</ref> <ref name="pmid10071091"> {{cite journal |author=Francis PT, Palmer AM, Snape M, Wilcock GK |title=The cholinergic hypothesis of Alzheimer's disease: a review of progress |journal=J. Neurol. Neurosurg. Psychiatr. |volume=66 |issue=2 |pages=137–47 |year=1999 |month=februar |pmid=10071091 |pmc=1736202 |doi= 10.1136/jnnp.66.2.137 |url=https://archive.org/details/sim_journal-of-neurology-neurosurgery-and-psychiatry_1999-02_66_2/page/137}}</ref> <ref name="pmid10369823">{{cite journal |author=Gambassi G, Landi F, Lapane KL, Sgadari A, Mor V, Bernabei R |title=Predictors of mortality in patients with Alzheimer's disease living in nursing homes |url=https://archive.org/details/sim_journal-of-neurology-neurosurgery-and-psychiatry_1999-07_67_1/page/59 |journal=J. Neurol. Neurosurg. Psychiatr. |volume=67 |issue=1 |pages=59–65 |year=1999 |month=juli |pmid=10369823 |pmc=1736445 |doi=10.1136/jnnp.67.1.59 }}</ref> <ref name="pmid10489656">{{cite journal |author=Schneider J, Murray J, Banerjee S, Mann A |title=EUROCARE: a cross-national study of co-resident spouse carers for people with Alzheimer's disease: I—Factors associated with carer burden |url=https://archive.org/details/sim_international-journal-of-geriatric-psychiatry_1999-08_14_8/page/651 |journal=International Journal of Geriatric Psychiatry |volume=14 |issue=8 |pages=651–661 |year=1999 |month=august |pmid=10489656 |doi=10.1002/(SICI)1099-1166(199908)14:8<651::AID-GPS992>3.0.CO;2-B |accessdate=2008-07-04 }}</ref> <ref name="pmid10489657">{{cite journal |author=Murray J, Schneider J, Banerjee S, Mann A |title=EUROCARE: a cross-national study of co-resident spouse carers for people with Alzheimer's disease: II—A qualitative analysis of the experience of caregiving |url=https://archive.org/details/sim_international-journal-of-geriatric-psychiatry_1999-08_14_8/page/662 |journal=International Journal of Geriatric Psychiatry |volume=14 |issue=8 |pages=662–667 |year=1999 |month=august |pmid=10489657 |doi=10.1002/(SICI)1099-1166(199908)14:8<662::AID-GPS993>3.0.CO;2-4 }}</ref> <ref name="pmid10653284"> {{cite journal |author=Förstl H, Kurz A |title=Clinical features of Alzheimer's disease |journal=European Archives of Psychiatry and Clinical Neuroscience |volume=249 |issue=6 |pages=288–290 |year=1999 |pmid=10653284 |doi=10.1007/s004060050101 }}</ref> <ref name="pmid11105732">{{cite journal |doi=10.4088/JCP.v61n1101 |author=Stahl SM |title=The new cholinesterase inhibitors for Alzheimer's disease, Part 2: illustrating their mechanisms of action |journal=[[J Clin Psychiatry]] |volume=61 |issue=11 |pages=813–814 |year=2000 |pmid=11105732 }}</ref> <ref name="pmid11220813">{{cite journal |author=Gitlin LN, Corcoran M, Winter L, Boyce A, Hauck WW |title=A randomized, controlled trial of a home environmental intervention: effect on efficacy and upset in caregivers and on daily function of persons with dementia |journal=Gerontologist |volume=41 |issue=1 |pages=4–14 |date=1. februar 2001 |pmid=11220813 |url=http://gerontologist.gerontologyjournals.org/cgi/pmidlookup?view=long&pmid=11220813 |accessdate=2008-07-15 }}{{død lenke|dato=juni 2017 |bot=InternetArchiveBot }}</ref> <ref name="pmid11342679">{{cite journal |author=Doody RS, Stevens JC, Beck C, ''et al.'' |title=Practice parameter: management of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology |url=https://archive.org/details/sim_neurology_2001-05-08_56_9/page/n74 |journal=Neurology |volume=56 |issue=9 |pages=1154–1166 |year=2001 |pmid=11342679 }}</ref> <ref name="pmid11445614">{{cite journal |author=Moore MJ, Zhu CW, Clipp EC |title=Informal costs of dementia care: estimates from the National Longitudinal Caregiver Study |journal=J Gerontol B Psychol Sci Soc Sci |volume=56 |issue=4 |pages=S219–28 |year=2001 |month=juli |pmid=11445614 }}</ref> <ref name="pmid11511058">{{cite journal |author=Pusey H, Richards D |title=A systematic review of the effectiveness of psychosocial interventions for carers of people with dementia |journal=Aging Ment Health |volume=5 |issue=2 |pages=107–19 |year=2001 |month=mai |pmid=11511058 |doi=10.1080/13607860120038302 }}</ref> <ref name="pmid11801334">{{cite journal |author=Mudher A, Lovestone S |title=Alzheimer's disease-do tauists and baptists finally shake hands? |url=https://archive.org/details/sim_trends-in-neurosciences_2002-01_25_1/page/22 |journal=Trends Neurosci. |volume=25 |issue=1 |pages=22–26 |year=2002 |month=januar |pmid=11801334 |doi=10.1016/S0166-2236(00)02031-2 }}</ref> <ref name="pmid11816795">{{cite journal |author=Kotzbauer PT, Trojanowsk JQ, Lee VM |title=Lewy body pathology in Alzheimer's disease |journal=J Mol Neurosci |volume=17 |issue=2 |pages=225–32 |year=2001 |month=oktober |pmid=11816795 |doi=10.1385/JMN:17:2:225 }}</ref> <ref name="pmid12028245">{{cite journal |author=Di Carlo A, Baldereschi M, Amaducci L, ''et al.'' |title=Incidence of dementia, Alzheimer's disease, and vascular dementia in Italy. The ILSA Study |url=https://archive.org/details/sim_journal-of-the-american-geriatrics-society_2002-01_50_1/page/n56 |journal=J Am Geriatr Soc |volume=50 |issue=1 |pages=41–8 |year=2002 |month=januar |pmid=12028245 |doi=10.1046/j.1532-5415.2002.50006.x |last12=Ilsa Working |first12=Group }}</ref> <ref name="pmid12222737">{{cite journal |author=Rondeau V |title=A review of epidemiologic studies on aluminum and silica in relation to Alzheimer's disease and associated disorders |journal=Rev Environ Health |volume=17 |issue=2 |pages=107–21 |year=2002 |pmid=12222737 }}</ref> <ref name="pmid12480441">{{cite journal |author=Ritchie K, Lovestone S |title=The dementias |url=https://archive.org/details/sim_the-lancet_2002-11-30_360_9347/page/n57 |journal=Lancet |volume=360 |issue=9347 |pages=1759–66 |year=2002 |month=november |pmid=12480441 |doi=10.1016/S0140-6736(02)11667-9 }}</ref> <ref name="pmid12519587">{{cite journal |author=Chung JC, Lai CK, Chung PM, French HP |title=Snoezelen for dementia |journal=Cochrane Database Syst Rev |issue=4 |pages=CD003152 |year=2002 |pmid=12519587 |doi=10.1002/14651858.CD003152 }}</ref> <ref name="pmid12580712">{{cite journal |author=Dodge HH, Shen C, Pandav R, DeKosky ST, Ganguli M |title=Functional transitions and active life expectancy associated with Alzheimer disease |journal=Arch. Neurol. |volume=60 |issue=2 |pages=253–9 |year=2003 |month=februar |pmid=12580712 |doi=10.1001/archneur.60.2.253 }}</ref> <ref name="pmid12603249">{{cite journal |author=Arnáiz E, Almkvist O |title=Neuropsychological features of mild cognitive impairment and preclinical Alzheimer's disease |journal=Acta Neurol. Scand., Suppl. |volume=179 |pages=34–41 |year=2003 |pmid=12603249 |doi=10.1034/j.1600-0404.107.s179.7.x |accessdate=2008-06-12 }}</ref> <ref name="pmid12854952">{{cite journal |author=Shega JW, Levin A, Hougham GW, ''et al.'' |title=Palliative Excellence in Alzheimer Care Efforts (PEACE): a program description |journal=J Palliat Med |volume=6 |issue=2 |pages=315–20 |year=2003 |month=april |pmid=12854952 |doi=10.1089/109662103764978641 }}</ref> <ref name="pmid12917907">{{cite journal |author=Neal M, Briggs M |title=Validation therapy for dementia |journal=Cochrane Database Syst Rev |issue=3 |pages=CD001394 |year=2003 |pmid=12917907 |doi=10.1002/14651858.CD001394 }}</ref> <ref name="pmid12927332">{{cite journal |author=Turner PR, O'Connor K, Tate WP, Abraham WC |title=Roles of amyloid precursor protein and its fragments in regulating neural activity, plasticity and memory |journal=Prog. Neurobiol. |volume=70 |issue=1 |pages=1–32 |year=2003 |month=mai |pmid=12927332 |doi=10.1016/S0301-0082(03)00089-3 }}</ref> <ref name="pmid12934968"> {{cite journal |author=Wenk GL |title=Neuropathologic changes in Alzheimer's disease |journal=J Clin Psychiatry |volume=64 Suppl 9 |pages=7–10 |year=2003 |pmid=12934968 }}</ref> <ref name="pmid12948999">{{cite journal |author=Spector A, Thorgrimsen L, Woods B, ''et al.'' |title=Efficacy of an evidence-based cognitive stimulation therapy programme for people with dementia: randomised controlled trial |journal=Br J Psychiatry |volume=183 |pages=248–254 |year=2003 |pmid=12948999 |doi=10.1192/bjp.183.3.248 }}</ref> <ref name="pmid14528050">{{cite journal |author=Hashimoto M, Rockenstein E, Crews L, Masliah E |title=Role of protein aggregation in mitochondrial dysfunction and neurodegeneration in Alzheimer's and Parkinson's diseases |journal=Neuromolecular Med. |volume=4 |issue=1–2 |pages=21–36 |year=2003 |pmid=14528050 |doi=10.1385/NMM:4:1-2:21 }}</ref> <ref name="pmid15004691">{{cite journal |author=Ohnishi S, Takano K |title=Amyloid fibrils from the viewpoint of protein folding |journal=Cell. Mol. Life Sci. |volume=61 |issue=5 |pages=511–24 |year=2004 |month=mars |pmid=15004691 |doi=10.1007/s00018-003-3264-8 }}</ref> <ref name="pmid15039236"> {{cite journal |author=Schmitz C, Rutten BP, Pielen A, ''et al.'' |title=Hippocampal neuron loss exceeds amyloid plaque load in a transgenic mouse model of Alzheimer's disease |journal=Am J Pathol |volume=164 |issue=4 |pages=1495–1502 |year=2004 |month=april |pmid=15039236 |pmc=1615337 |last12=Steinbusch |first12=HW |last13=Pradier |first13=L |last14=Bayer |first14=TA }}</ref> <ref name="pmid15068977">{{cite journal |author=Larson EB, Shadlen MF, Wang L, ''et al.'' |title=Survival after initial diagnosis of Alzheimer disease |journal=Ann. Intern. Med. |volume=140 |issue=7 |pages=501–9 |year=2004 |month=april |pmid=15068977 }}</ref> <ref name="pmid15184601">{{cite journal |author=Tiraboschi P, Hansen LA, Thal LJ, Corey-Bloom J |title=The importance of neuritic plaques and tangles to the development and evolution of AD |url=https://archive.org/details/sim_neurology_2004-06-08_62_11/page/n140 |journal=Neurology |volume=62 |issue=11 |pages=1984–9 |year=2004 |month=juni |pmid=15184601 }}</ref> <ref name="pmid15236795"> {{cite journal |author=Shen ZX |title=Brain cholinesterases: II. The molecular and cellular basis of Alzheimer's disease |journal=Med Hypotheses |volume=63 |issue=2 |pages=308–21 |year=2004 |pmid=15236795 |doi=10.1016/j.mehy.2004.02.031 }}</ref> <ref name="pmid15297089"> {{cite journal | author = Dunne TE, Neargarder SA, Cipolloni PB, Cronin-Golomb A | title = Visual contrast enhances food and liquid intake in advanced Alzheimer's disease | url = https://archive.org/details/sim_clinical-nutrition_2004-08_23_4/page/533 | journal = Clinical Nutrition | volume = 23 | issue = 4 | pages = 533–538 | year = 2004 | pmid = 15297089 | doi = 10.1016/j.clnu.2003.09.015 }}</ref> <ref name="pmid15324363">{{cite journal |author=Bäckman L, Jones S, Berger AK, Laukka EJ, Small BJ |title=Multiple cognitive deficits during the transition to Alzheimer's disease |url=https://archive.org/details/sim_journal-of-internal-medicine_2004-09_256_3/page/195 |journal=J Intern Med |volume=256 |issue=3 |pages=195–204 |year=2004 |month=september |pmid=15324363 |doi=10.1111/j.1365-2796.2004.01386.x }}</ref> <ref name="pmid15461232">{{cite journal |author=Sherman FT |url=http://www.modernmedicine.com/modernmedicine/article/articleDetail.jsp?id=121676 |title= Did President Reagan have mild cognitive impairment while in office? Living longer with Alzheimer's Disease |journal=Geriatrics |volume=59 |issue=9 |pages=11, 15 |year=2004 |month=september |pmid=15461232 }}</ref> <ref name="pmid15495043">{{cite journal |author=Areosa Sastre A, McShane R, Sherriff F |title=Memantine for dementia |journal=[[Cochrane Database Syst Rev]] |issue=4 |pages=CD003154 |year=2004 |pmid=15495043 |doi=10.1002/14651858.CD003154.pub2 }}</ref> <ref name="pmid15545324">{{cite journal |author=Dougall NJ, Bruggink S, Ebmeier KP |title=Systematic review of the diagnostic accuracy of 99mTc-HMPAO-SPECT in dementia |journal=Am J Geriatr Psychiatry |volume=12 |issue=6 |pages=554–70 |year=2004 |pmid=15545324 |doi=10.1176/appi.ajgp.12.6.554 }}</ref> <ref name="pmid15574466">{{cite journal |author=Garrard P, Maloney LM, Hodges JR, Patterson K |url=http://brain.oxfordjournals.org/cgi/content/full/128/2/250 |title= The effects of very early Alzheimer's disease on the characteristics of writing by a renowned author |journal=Brain |volume=128 |issue=Pt 2 |pages=250–60 |year=2005 |month=februar |pmid=15574466 |doi=10.1093/brain/awh341 }}</ref> <ref name="pmid15615638"> {{cite journal |author=Iqbal K, Alonso Adel C, Chen S, ''et al.'' |title=Tau pathology in Alzheimer disease and other tauopathies |journal=Biochim Biophys Acta |volume=1739 |issue=2–3 |pages=198–210 |year=2005 |month=januar |pmid=15615638 |doi=10.1016/j.bbadis.2004.09.008 |url= |last12=Grundke-Iqbal |first12=I }}</ref> <ref name="pmid15639317">{{cite journal |author=Lott IT, Head E |title=Alzheimer disease and Down syndrome: factors in pathogenesis |url=https://archive.org/details/sim_neurobiology-of-aging_2005-03_26_3/page/n112 |journal=Neurobiol Aging |volume=26 |issue=3 |pages=383–89 |year=2005 |month=mars |pmid=15639317 |doi=10.1016/j.neurobiolaging.2004.08.005 }}</ref> <ref name="pmid15681814">{{cite journal |author=Greig NH, Mattson MP, Perry T, ''et al.'' |title=New therapeutic strategies and drug candidates for neurodegenerative diseases: p53 and TNF-alpha inhibitors, and GLP-1 receptor agonists |journal=Ann. N. Y. Acad. Sci. |volume=1035 |pages=290–315 |year=2004 |month=desember |pmid=15681814 |doi=10.1196/annals.1332.018 }}</ref> <ref name="pmid15685097">{{cite journal |author=Bonin-Guillaume S, Zekry D, Giacobini E, Gold G, Michel JP |title=Impact économique de la démence (English: The economical impact of dementia) |language=fransk |journal=Presse Med |issn=0755-4982 |volume=34 |issue=1 |pages=35–41 |year=2005 |month=januar |pmid=15685097 }}</ref> <ref name="pmid15738860">{{cite journal |author=Antoine C, Antoine P, Guermonprez P, Frigard B |title=[Awareness of deficits and anosognosia in Alzheimer's disease.] |language=fransk |journal=Encephale |volume=30 |issue=6 |pages=570–7 |year=2004 |pmid=15738860 |doi=10.1016/S0013-7006(04)95472-3 }}</ref> <ref name="pmid15787600">{{cite journal |author=Hooper NM |title=Roles of proteolysis and lipid rafts in the processing of the amyloid precursor protein and prion protein |journal=Biochem. Soc. Trans. |volume=33 |issue=Pt 2 |pages=335–8 |year=2005 |month=april |pmid=15787600 |doi=10.1042/BST0330335 }}</ref> <ref name="pmid15788549">{{cite journal |author=Venneri A, Forbes-Mckay KE, Shanks MF |title=Impoverishment of spontaneous language and the prediction of Alzheimer's disease |journal=Brain |volume=128 |issue=Pt 4 |pages=E27 |year=2005 |month=april |pmid=15788549 |doi=10.1093/brain/awh419 |url= }}</ref> <ref name="pmid15846613">{{cite journal |author=Woods B, Spector A, Jones C, Orrell M, Davies S |title=Reminiscence therapy for dementia |journal=Cochrane Database Syst Rev |issue=2 |pages=CD001120 |year=2005 |pmid=15846613 |doi=10.1002/14651858.CD001120.pub2 }}</ref> <ref name="pmid15860476">{{cite journal |author=Gitlin LN, Hauck WW, Dennis MP, Winter L |title=Maintenance of effects of the home environmental skill-building program for family caregivers and individuals with Alzheimer's disease and related disorders |url=https://archive.org/details/sim_journals-of-gerontology_2005-03_60a_3/page/368 |journal=J. Gerontol. A Biol. Sci. Med. Sci. |volume=60 |issue=3 |pages=368–74 |year=2005 |month=mars |pmid=15860476 }}</ref> <ref name="pmid15883266">{{cite journal |author=Ganguli M, Dodge HH, Shen C, Pandav RS, DeKosky ST |title=Alzheimer disease and mortality: a 15-year epidemiological study |journal=Arch. Neurol. |volume=62 |issue=5 |pages=779–84 |year=2005 |month=mai |pmid=15883266 |doi=10.1001/archneur.62.5.779 }}</ref> <ref name="pmid16197855">{{cite journal |author=Cruz VT, Pais J, Teixeira A, Nunes B |title=[The initial symptoms of Alzheimer disease: caregiver perception] |language=portugisisk |journal=Acta Med Port |volume=17 |issue=6 |pages=435–44 |year=2004 |pmid=16197855 }}</ref> <ref name="pmid16227450">{{cite journal |author=Boothby LA, Doering PL |title=Vitamin C and vitamin E for Alzheimer's disease |journal=Ann Pharmacother |volume=39 |issue=12 |pages=2073–80 |year=2005 |month=desember |pmid=16227450 |doi=10.1345/aph.1E495 |url=https://archive.org/details/sim_annals-of-pharmacotherapy_2005-12_39_12/page/2073 }}</ref> <ref name="pmid16323385">{{cite journal |author=Bottino CM, Carvalho IA, Alvarez AM, ''et al.'' |title=Cognitive rehabilitation combined with drug treatment in Alzheimer's disease patients: a pilot study |journal=Clin Rehabil |volume=19 |issue=8 |pages=861–869 |year=2005 |pmid=16323385 |doi=10.1191/0269215505cr911oa }}</ref> <ref name="pmid16327345">{{cite journal |author=Harvey PD, Moriarty PJ, Kleinman L, ''et al.'' |title=The validation of a caregiver assessment of dementia: the Dementia Severity Scale |journal=Alzheimer Dis Assoc Disord |volume=19 |issue=4 |pages=186–94 |year=2005 |pmid=16327345 |doi=10.1097/01.wad.0000189034.43203.60 }}</ref> <ref name="pmid16360788">{{cite journal |author = Ferri CP, Prince M, Brayne C, ''et al.'' |title = Global prevalence of dementia: a Delphi consensus study |journal = Lancet |volume = 366 |issue = 9503 |pages = 2112–7 |year = 2005 |month = desember |pmid = 16360788 |pmc = 2850264 |doi = 10.1016/S0140-6736(05)67889-0 |url = http://www.sbgg.org.br/profissional/artigos/pdf/demencia_mundo.pdf |accessdate = 2008-06-25 |format = PDF |last12 = Mathers |first12 = C |last13 = Menezes |first13 = PR |last14 = Rimmer |first14 = E |last15 = Scazufca |first15 = M |last16 = Alzheimer's Disease |first16 = International |url-status = dead |archiveurl = https://web.archive.org/web/20080625071754/http://www.sbgg.org.br/profissional/artigos/pdf/demencia_mundo.pdf |archivedate = 2008-06-25 }}</ref> <ref name="pmid16401889">{{cite journal |author=Wimo A, Jonsson L, Winblad B |title=An estimate of the worldwide prevalence and direct costs of dementia in 2003 |journal=Dement Geriatr Cogn Disord |volume=21 |issue=3 |pages=175–81 |year=2006 |pmid=16401889 |doi=10.1159/000090733 }}</ref> <ref name="pmid16415742">{{cite journal |author=Dennehy C |title=Analysis of patients' rights: dementia and PEG insertion |journal=Br J Nurs |volume=15 |issue=1 |pages=18–20 |year=2006 |pmid=16415742 }}</ref> <ref name="pmid16424917">{{cite journal |author=Lipton SA |title=Paradigm shift in neuroprotection by NMDA receptor blockade: memantine and beyond |journal=[[Nat Rev Drug Discov]] |volume=5 |issue=2 |pages=160–170 |year=2006 |pmid=16424917 |doi=10.1038/nrd1958 }}</ref> <ref name="pmid16437430">{{cite journal |author=Birks J, Harvey RJ |title=Donepezil for dementia due to Alzheimer's disease |journal=[[Cochrane Database Syst Rev]] |issue=1 |pages=CD001190 |date=25. januar 2006 |pmid=16437430 |doi=10.1002/14651858.CD001190.pub2 }}</ref> <ref name="pmid16437532">{{cite journal |author=Birks J |title=Cholinesterase inhibitors for Alzheimer's disease |journal=Cochrane Database Syst Rev |issue=1 |pages=CD005593 |year=2006 |pmid=16437532 |doi=10.1002/14651858.CD005593 |last2=Birks |first2=Jacqueline }}</ref> <ref name="pmid16556924">{{cite journal |author=Chernoff R |title=Tube feeding patients with dementia |url=https://archive.org/details/sim_nutrition-in-clinical-practice_2006-04_21_2/page/142 |journal=Nutr Clin Pract |volume=21 |issue=2 |pages=142–6 |year=2006 |month=april |pmid=16556924 |doi=10.1177/0115426506021002142 }}</ref> <ref name="pmid16567625">{{cite journal |author=Mahley RW, Weisgraber KH, Huang Y |title=Apolipoprotein E4: a causative factor and therapeutic target in neuropathology, including Alzheimer's disease |journal=Proc. Natl. Acad. Sci. U.S.A. |volume=103 |issue=15 |pages=5644–51 |year=2006 |month=april |pmid=16567625 |pmc=1414631 |doi=10.1073/pnas.0600549103 |url= }}</ref> <ref name="pmid16676288">{{cite journal |author=Jönsson L, Eriksdotter Jönhagen M, Kilander L, ''et al.'' |title=Determinants of costs of care for patients with Alzheimer's disease |url=https://archive.org/details/sim_international-journal-of-geriatric-psychiatry_2006-05_21_5/page/449 |journal=Int J Geriatr Psychiatry |volume=21 |issue=5 |pages=449–59 |year=2006 |month=mai |pmid=16676288 |doi=10.1002/gps.1489 }}</ref> <ref name="pmid16785801">{{cite journal |author=Bonte FJ, Harris TS, Hynan LS, Bigio EH, White CL |title=Tc-99m HMPAO SPECT in the differential diagnosis of the dementias with histopathologic confirmation |url=https://archive.org/details/sim_clinical-nuclear-medicine_2006-07_31_7/page/376 |journal=Clin Nucl Med |volume=31 |issue=7 |pages=376–8 |year=2006 |month=juli |pmid=16785801 |doi=10.1097/01.rlu.0000222736.81365.63 }}</ref> <ref name="pmid16822978">{{cite journal |author=Priller C, Bauer T, Mitteregger G, Krebs B, Kretzschmar HA, Herms J |title=Synapse formation and function is modulated by the amyloid precursor protein |journal=J. Neurosci. |volume=26 |issue=27 |pages=7212–21 |year=2006 |month=juli |pmid=16822978 |doi=10.1523/JNEUROSCI.1450-06.2006 }}</ref> <ref name="pmid16858741">{{cite journal |author=Suh GH, Knapp M, Kang CJ |title=The economic costs of dementia in Korea, 2002 |url=https://archive.org/details/sim_international-journal-of-geriatric-psychiatry_2006-08_21_8/page/722 |journal=Int J Geriatr Psychiatry |volume=21 |issue=8 |pages=722–8 |year=2006 |month=august |pmid=16858741 |doi=10.1002/gps.1552 }}</ref> <ref name="pmid16870037">{{cite journal |author=Allegri RF, Butman J, Arizaga RL, ''et al.'' |title=Economic impact of dementia in developing countries: an evaluation of costs of Alzheimer-type dementia in Argentina |journal=Int Psychogeriatr |volume=19 |issue=4 |pages=705–18 |year=2007 |month=august |pmid=16870037 |doi=10.1017/S1041610206003784 }}</ref> <ref name="pmid16876668">{{cite journal |author=Blennow K, de Leon MJ, Zetterberg H |title=Alzheimer's disease |journal=Lancet |volume=368 |issue=9533 |pages=387–403 |year=2006 |month=juli |pmid=16876668 |doi=10.1016/S0140-6736(06)69113-7 |url= }}</ref> <ref name="pmid16904243"> {{cite journal |author=Nistor M, Don M, Parekh M, ''et al.'' |title=Alpha- and beta-secretase activity as a function of age and beta-amyloid in Down syndrome and normal brain |url=https://archive.org/details/sim_neurobiology-of-aging_2007-10_28_10/page/1493 |journal=Neurobiol Aging |volume=28 |issue=10 |pages=1493–1506 |year=2007 |month=oktober |pmid=16904243 |doi=10.1016/j.neurobiolaging.2006.06.023 |last12=Head |first12=E }}</ref> <ref name="pmid16917199">PMID 16917199</ref> <ref name="pmid16926764">[635] ^ Etanercept research: **{{cite journal |author=Tobinick E, Gross H, Weinberger A, Cohen H |title=TNF-alpha modulation for treatment of Alzheimer's disease: a 6-month pilot study |journal=MedGenMed |volume=8 |issue=2 |page=25 |year=2006 |pmid=16926764 |pmc=1785182 }} **{{cite journal |author=Griffin WS |title=Perispinal etanercept: potential as an Alzheimer therapeutic |journal=J Neuroinflammation |volume=5 |page=3 |year=2008 |pmid=18186919 |pmc=2241592 |doi=10.1186/1742-2094-5-3 }} **{{cite journal |author=Tobinick E |title=Perispinal etanercept for treatment of Alzheimer's disease |journal=Curr Alzheimer Res |volume=4 |issue=5 |pages=550–2 |year=2007 |month=desember |pmid=18220520 |doi=10.2174/156720507783018217 }} </ref> <ref name="pmid17018549">{{cite journal |author=Klafki HW, Staufenbiel M, Kornhuber J, Wiltfang J |title=Therapeutic approaches to Alzheimer's disease |url=https://archive.org/details/sim_brain_2006-11_129_11/page/2840 |journal=Brain |volume=129 |issue=Pt 11 |pages=2840–55 |year=2006 |month=november |pmid=17018549 |doi=10.1093/brain/awl280 }}</ref> <ref name="pmid17096455">{{cite journal |author=Robinson L, Hutchings D, Dickinson HO, ''et al.'' |title=Effectiveness and acceptability of non-pharmacological interventions to reduce wandering in dementia: a systematic review |url=https://archive.org/details/sim_international-journal-of-geriatric-psychiatry_2007-01_22_1/page/n12 |journal=Int J Geriatr Psychiatry |volume=22 |issue=1 |pages=9–22 |year=2007 |pmid=17096455 |doi=10.1002/gps.1643 }}</ref> <ref name="pmid17127334">{{cite journal |author=Chun W, Johnson GV |title=The role of tau phosphorylation and cleavage in neuronal cell death |journal=Front Biosci |volume=12 |pages=733–56 |year=2007 |pmid=17127334 |doi=10.2741/2097 }}</ref> <ref name="pmid17222085">{{cite journal |author=Waldemar G, Dubois B, Emre M, ''et al.'' |title=Recommendations for the diagnosis and management of Alzheimer's disease and other disorders associated with dementia: EFNS guideline |journal=Eur J Neurol |volume=14 |issue=1 |pages=e1–26 |year=2007 |month=januar |pmid=17222085 |doi=10.1111/j.1468-1331.2006.01605.x }}</ref> <ref name="pmid17251419"> {{cite journal |author=Lacor PN,''et al.'' |title=Aß Oligomer-Induced Aberrations in Synapse Composition, Shape, and Density Provide a Molecular Basis for Loss of Connectivity in Alzheimer's Disease |url=https://archive.org/details/sim_journal-of-neuroscience_2007-01-24_27_4/page/n83 |journal=Journal of Neuroscience |volume=27 |issue=4 |pages=796–807 |year=2007 |month=januar |pmid=17251419 |doi=10.1523/JNEUROSCI.3501-06.2007 |last2=Buniel |first2=MC |last3=Furlow |first3=PW |last4=Clemente |first4=AS |last5=Velasco |first5=PT |last6=Wood |first6=M |last7=Viola |first7=KL |last8=Klein |first8=WL }}</ref> <ref name="pmid17253573">{{cite journal |author=Hermans DG, Htay UH, McShane R |title=Non-pharmacological interventions for wandering of people with dementia in the domestic setting |journal=Cochrane Database Syst Rev |issue=1 |pages=CD005994 |year=2007 |pmid=17253573 |doi=10.1002/14651858.CD005994.pub2 }}</ref> <ref name="pmid17254019">{{cite journal |author=Shioi J, Georgakopoulos A, Mehta P, ''et al.'' |title=FAD mutants unable to increase neurotoxic Aβ 42 suggest that mutation effects on neurodegeneration may be independent of effects on Abeta. |journal=J Neurochem. |volume=101 |issue=3 |pages=674–81 |year=2007 |month=mai |pmid=17254019 |doi=10.1111/j.1471-4159.2006.04391.x }}</ref> <ref name="pmid17279076"> {{cite journal |author=Petersen RC |title=The current status of mild cognitive impairment—what do we tell our patients? |journal=Nat Clin Pract Neurol |volume=3 |issue=2 |pages=60–1 |year=2007 |month=februar |pmid=17279076 |doi=10.1038/ncpneuro0402 }}</ref> <ref name="pmid17407994">{{cite journal |author=Mendez MF |title=The accurate diagnosis of early-onset dementia |journal=International Journal of Psychiatry Medicine |volume=36 |issue=4 |pages=401–412 |year=2006 |pmid=17407994 |doi=10.2190/Q6J4-R143-P630-KW41 }}</ref> <ref name="pmid17424907">{{cite journal |author=Chen X, Yan SD |title=Mitochondrial Abeta: a potential cause of metabolic dysfunction in Alzheimer's disease |journal=IUBMB Life |volume=58 |issue=12 |pages=686–94 |year=2006 |month=desember |pmid=17424907 |doi=10.1080/15216540601047767}}</ref> <ref name="pmid17483665">{{cite journal |author=Rosendorff C, Beeri MS, Silverman JM |title=Cardiovascular risk factors for Alzheimer's disease |journal=Am J Geriatr Cardiol |volume=16 |issue=3 |pages=143–9 |year=2007 |pmid=17483665 |doi=10.1111/j.1076-7460.2007.06696.x }}</ref> <ref name="pmid17495754">{{cite journal |author=Potter GG, Steffens DC |title=Contribution of depression to cognitive impairment and dementia in older adults |journal=Neurologist |volume=13 |issue=3 |pages=105–17 |year=2007 |month=mai |pmid=17495754 |doi=10.1097/01.nrl.0000252947.15389.a9 }}</ref> <ref name="pmid17522444">{{cite journal |author=Shcherbatykh I, Carpenter DO |title=The role of metals in the etiology of Alzheimer's disease |journal=J Alzheimers Dis |volume=11 |issue=2 |pages=191–205 |year=2007 |month=mai |pmid=17522444 }}</ref> <ref name="pmid17604998">{{cite journal |author=Hernández F, Avila J |title=Tauopathies |url=https://archive.org/details/sim_cellular-and-molecular-life-sciences_2007-09_64_17/page/2219 |journal=Cell. Mol. Life Sci. |volume=64 |issue=17 |pages=2219–33 |year=2007 |month=september |pmid=17604998 |doi=10.1007/s00018-007-7220-x }}</ref> <ref name="pmid17612054">{{cite journal |author=Szekely CA, Town T, Zandi PP |title=NSAIDs for the chemoprevention of Alzheimer's disease |journal=Subcell Biochem |volume=42 |issue= |pages=229–48 |year=2007 |month= |pmid=17612054 |doi=10.1007/1-4020-5688-5_11 }}</ref> <ref name="pmid17612711">{{cite journal |author=Marksteiner J, Hinterhuber H, Humpel C |title=Cerebrospinal fluid biomarkers for diagnosis of Alzheimer's disease: beta-amyloid(1-42), tau, phospho-tau-181 and total protein |journal=Drugs Today |volume=43 |issue=6 |pages=423–31 |year=2007 |month=juni |pmid=17612711 |doi=10.1358/dot.2007.43.6.1067341 }}</ref> <ref name="pmid17616482">{{cite journal |author=Dubois B, Feldman HH, Jacova C, ''et al.'' |title=Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria |journal=Lancet Neurol |volume=6 |issue=8 |pages=734–46 |year=2007 |month=august |pmid=17616482 |doi=10.1016/S1474-4422(07)70178-3 |last12=O'brien |first12=J |last13=Pasquier |first13=F |last14=Robert |first14=P |last15=Rossor |first15=M |last16=Salloway |first16=S |last17=Stern |first17=Y |last18=Visser |first18=PJ |last19=Scheltens |first19=P }}</ref> <ref name="pmid17622778">{{cite journal |author=Van Broeck B, Van Broeckhoven C, Kumar-Singh S |title=Current insights into molecular mechanisms of Alzheimer disease and their implications for therapeutic approaches |journal=Neurodegener Dis |volume=4 |issue=5 |pages=349–65 |year=2007 |pmid=17622778 |doi=10.1159/000105156 }}</ref> <ref name="pmid17636652">{{cite journal |author=Spector A, Orrell M, Davies S, Woods B |title=Withdrawn: Reality orientation for dementia |journal=Cochrane Database Syst Rev |issue=3 |pages=CD001119 |year=2000 |pmid=17636652 |doi=10.1002/14651858.CD001119.pub2 }}</ref> <ref name="pmid17662119">{{cite journal |author=Thompson CA, Spilsbury K, Hall J, Birks Y, Barnes C, Adamson J |title=Systematic review of information and support interventions for caregivers of people with dementia |journal=BMC Geriatr |volume=7 |page=18 |year=2007 |pmid=17662119 |pmc=1951962 |doi=10.1186/1471-2318-7-18 }}</ref> <ref name="pmid17727890">{{cite journal |author=Bermejo-Pareja F, Benito-León J, Vega S, Medrano MJ, Román GC |title=Incidence and subtypes of dementia in three elderly populations of central Spain |journal=J. Neurol. Sci. |volume=264 |issue=1–2 |pages=63–72 |year=2008 |month=januar |pmid=17727890 |doi=10.1016/j.jns.2007.07.021 }}</ref> <ref name="pmid17823840"> {{cite journal |author=Tabert MH, Liu X, Doty RL, Serby M, Zamora D, Pelton GH, Marder K, Albers MW, Stern Y, Devanand DP |title=A 10-item smell identification scale related to risk for Alzheimer's disease |url=https://archive.org/details/sim_annals-of-neurology_2005-07_58_1/page/155 |journal=Ann. Neurol. |volume=58 |issue=1 |pages=155–160 |year=2005 |pmid=15984022 |doi=10.1002/ana.20533 }}</ref> <ref name="pmid17877925">{{cite journal |author=Kuller LH |title=Statins and dementia |journal=Curr Atheroscler Rep |volume=9 |issue=2 |pages=154–61 |year=2007 |month=august |pmid=17877925 |doi=10.1007/s11883-007-0012-9 }}</ref> <ref name="pmid17927279">{{cite journal |author=Reiss AB, Wirkowski E |title=Role of HMG-CoA reductase inhibitors in neurological disorders: progress to date |journal=Drugs |volume=67 |issue=15 |pages=2111–20 |year=2007 |pmid=17927279|doi=10.2165/00003495-200767150-00001 }}</ref> <ref name="pmid18044111">{{cite journal |author=Zhu CW, Sano M |title=Economic considerations in the management of Alzheimer's disease |journal=Clin Interv Aging |volume=1 |issue=2 |pages=143–54 |year=2006 |pmid=18044111 |doi=10.2147/ciia.2006.1.2.143 |pmc=2695165 }}</ref> <ref name="pmid18044984">{{cite journal |author=Raschetti R, Albanese E, Vanacore N, Maggini M |title=Cholinesterase inhibitors in mild cognitive impairment: a systematic review of randomised trials |journal=[[PLoS Med]] |volume=4 |issue=11 |pages=e338 |year=2007 |pmid=18044984 |doi=10.1371/journal.pmed.0040338 |pmc=2082649 }}</ref> <ref name="pmid18088206">{{cite journal |author=Solfrizzi V, Capurso C, D'Introno A, ''et al.'' |title=Lifestyle-related factors in predementia and dementia syndromes |journal=Expert Rev Neurother |volume=8 |issue=1 |pages=133–58 |year=2008 |month=januar |pmid=18088206 |doi=10.1586/14737175.8.1.133 |url= }}</ref> <ref name="pmid18299540">{{cite journal |author=Patterson C, Feightner JW, Garcia A, Hsiung GY, MacKnight C, Sadovnick AD |title=Diagnosis and treatment of dementia: 1. Risk assessment and primary prevention of Alzheimer disease |journal=CMAJ |volume=178 |issue=5 |pages=548–56 |year=2008 |month=februar |pmid=18299540 |pmc=2244657 |doi=10.1503/cmaj.070796 }}</ref> <ref name="pmid18316756">{{cite journal |author=Raina P, Santaguida P, Ismaila A, ''et al.'' |title=Effectiveness of cholinesterase inhibitors and memantine for treating dementia: evidence review for a clinical practice guideline |journal=[[Annals of Internal Medicine]] |volume=148 |issue=5 |pages=379–397 |year=2008 |pmid=18316756 }}</ref> <ref name="pmid18332245">{{cite journal |author=Waring SC, Rosenberg RN |title=Genome-wide association studies in Alzheimer disease |journal=Arch Neurol |volume=65 |issue=3 |pages=329–34 |year=2008 |month=mars |pmid=18332245 |doi=10.1001/archneur.65.3.329 }}</ref> <ref name="pmid18445747">{{cite journal |author=O'Brien JT |title=Role of imaging techniques in the diagnosis of dementia |journal=Br J Radiol |date=desember 2007 |volume=80 |issue=Spec No 2 |pages=S71–7 |pmid=18445747 |doi=10.1259/bjr/33117326 }}</ref> <ref name="pmid18487848"> {{cite journal |author=Itzhaki RF, Wozniak MA |title=Herpes simplex virus type 1 in Alzheimer's disease: the enemy within |journal=J Alzheimers Dis |volume=13 |issue=4 |pages=393–405 |year=2008 |month=mai |pmid=18487848 |doi= |issn=1387-2877 |url=http://iospress.metapress.com/openurl.asp?genre=article&issn=1387-2877&volume=13&issue=4&spage=393 }}</ref> <ref name="pmid18640457">{{cite journal |author=Doody RS, Gavrilova SI, Sano M, ''et al.'' |title=Effect of dimebon on cognition, activities of daily living, behaviour, and global function in patients with mild-to-moderate Alzheimer's disease: a randomised, double-blind, placebo-controlled study |journal=Lancet |volume=372 |issue=9634 |pages=207–15 |year=2008 |month=juli |pmid=18640457 |doi=10.1016/S0140-6736(08)61074-0 }}</ref> <ref name="pmid18640458"> {{cite journal |author=Holmes C, Boche D, Wilkinson D, ''et al.'' |title=Long-term effects of Abeta42 immunisation in Alzheimer's disease: follow-up of a randomised, placebo-controlled phase I trial |journal=Lancet |volume=372 |issue=9634 |pages=216–23 |year=2008 |month=juli |pmid=18640458 |doi=10.1016/S0140-6736(08)61075-2 |last12=Nicoll |first12=JA }}</ref> <ref name="pmid19023729">{{cite journal |author=Zetteler J |title=Effectiveness of simulated presence therapy for individuals with dementia: a systematic review and meta-analysis |journal=Aging Ment Health |volume=12 |issue=6 |pages=779–85 |year=2008 |month=november |pmid=19023729 |doi=10.1080/13607860802380631 }}</ref> <ref name="pmid19026089">{{cite journal |author=Paradise M, Cooper C, Livingston G |title=Systematic review of the effect of education on survival in Alzheimer's disease |journal=Int Psychogeriatr |volume=21 |issue=1 |pages=25–32 |year=2009 |month=februar |pmid=19026089 |doi=10.1017/S1041610208008053 }}</ref> <ref name="pmid19138567"> {{cite journal |author=Ballard C, Hanney ML, Theodoulou M, Douglas S, McShane R, Kossakowski K, Gill R, Juszczak E, Yu L-M, Jacoby R |title=The dementia antipsychotic withdrawal trial (DART-AD): long-term follow-up of a randomised placebo-controlled trial |journal=[[Lancet Neurology]] |date=9. januar 2009 |pmid=19138567 |doi=10.1016/S1474-4422(08)70295-3 |laysummary=http://www.physorg.com/news150695213.html |volume=8 |page=151 |issue=2 }}</ref> <ref name="pmid19242475"> {{cite journal |author=Lauren J, Gimbel D, ''et al.'' |title=Cellular prion protein mediates impairment of synaptic plasticity by amyloid-beta oligomers |url=https://archive.org/details/sim_nature-uk_2009-02-26_457_7233/page/n90 |journal=Nature |volume=457 |issue=7233 |pages=1128–32 |year=2009 |month=februar |pmid=19242475 |doi=10.1038/nature07761 |pmc=2748841 }}</ref> <ref name="pmid19370562">{{cite journal |journal=[[Cochrane Database Syst Rev]] |date=15. april 2009 |pages=CD001191 |issue=2 |title=Rivastigmine for Alzheimer's disease |author=Birks J, Grimley Evans J, Iakovidou V, Tsolaki M, Holt FE |pmid=19370562 |doi=10.1002/14651858.CD001191.pub2 }}</ref> <ref name="pmid19370593">{{cite journal |author=Farquhar C, Marjoribanks J, Lethaby A, Suckling JA, Lamberts Q |title=Long term hormone therapy for perimenopausal and postmenopausal women |journal=Cochrane Database Syst Rev |volume= |issue=2 |pages=CD004143 |date=15. april 2009 |pmid=19370593 |doi=10.1002/14651858.CD004143.pub3 }}</ref> <ref name="pmid19401958">{{cite journal |author=Barrett-Connor E, Laughlin GA |title=Endogenous and exogenous estrogen, cognitive function, and dementia in postmenopausal women: evidence from epidemiologic studies and clinical trials |journal=Semin Reprod Med |volume=27 |issue=3 |date=mai 2009 |pages=275–82 |pmc=2701737 |doi=10.1055/s-0029-1216280 |pmid=19401958 |last1=Barrett-Connor |first1=E |last2=Laughlin |first2=GA }}</ref> <ref name="pmid19847050">{{cite journal |author=Rabinovici GD, Jagust WJ |journal=Behav Neurol |year=2009 |volume=21 |issue=1 |pages=117–28 |title=Amyloid imaging in aging and dementia: testing the amyloid hypothesis in vivo |pmid=19847050 |pmc=2804478 |doi=10.3233/BEN-2009-0232 |doi_brokendate=2010-08-25 }}</ref> <ref name="pmid20501908">{{cite journal |doi=10.2967/jnumed.109.069088 |journal=J Nucl Med |date=juni 2010 |volume=51 |issue=6 |pages=913–20 |title=In vivo imaging of amyloid deposition in Alzheimer disease using the radioligand 18F-AV-45 (flobetapir F 18) |url=https://archive.org/details/sim_journal-of-nuclear-medicine_2010-06_51_6/page/913 |author=Wong DF, Rosenberg PB, Zhou Y, Kumar A, Raymont V, Ravert HT, Dannals RF, Nandi A, Brasić JR, Ye W, Hilton J, Lyketsos C, Kung HF, Joshi AD, Skovronsky DM, Pontecorvo MJ |pmid=20501908 |laysummary=http://www.diagnosticimaging.com/news/display/article/113619/1598949 }}</ref> <ref name="pmid9661992a">{{cite journal |author=Berchtold NC, Cotman CW |title=Evolution in the conceptualization of dementia and Alzheimer's disease: Greco-Roman period to the 1960s |journal=Neurobiol. Aging |volume=19 |issue=3 |pages=173–89 |year=1998 |pmid=9661992 |doi=10.1016/S0197-4580(98)00052-9 }}</ref> <ref name="pmid9661992b">{{cite journal |author=Berchtold NC, Cotman CW |title=Evolution in the conceptualization of dementia and Alzheimer's disease: Greco-Roman period to the 1960s |journal=Neurobiology of Aging |volume=19 |issue=3 |pages=173–189 |year=1998 |pmid=9661992 |doi=10.1016/S0197-4580(98)00052-9 }}</ref> <ref name="pracGuideAPA">{{cite web | url=http://www.psychiatryonline.com/pracGuide/loadGuidelinePdf.aspx?file=AlzPG101007 | format=PDF | title =Practice Guideline for the Treatment of Patients with Alzheimer's disease and Other Dementias | publisher =[[American Psychiatric Association]] | month=oktober | year=2007 | accessdate=2007-12-28 | doi=10.1176/appi.books.9780890423967.152139 }}</ref> <ref name="prevention1">{{cite web |title = Can Alzheimer's disease be prevented |url = http://www.nia.nih.gov/NR/rdonlyres/63B5A29C-F943-4DB7-91B4-0296772973F3/0/CanADbePrevented.pdf |format = pdf |publisher = National Institute on Aging |accessdate = 2008-02-29 |date = 2006-08-29 |archiveurl = https://web.archive.org/web/20061002125551/http://www.nia.nih.gov/NR/rdonlyres/63B5A29C-F943-4DB7-91B4-0296772973F3/0/CanADbePrevented.pdf |archivedate = 2006-10-02 |url-status = død }}</ref> </references>
Redigeringsforklaring:
Merk at alle bidrag til Wikisida.no anses som frigitt under Creative Commons Navngivelse-IkkeKommersiell-DelPåSammeVilkår (se
Wikisida.no:Opphavsrett
for detaljer). Om du ikke vil at ditt materiale skal kunne redigeres og distribueres fritt må du ikke lagre det her.
Du lover oss også at du har skrevet teksten selv, eller kopiert den fra en kilde i offentlig eie eller en annen fri ressurs.
Ikke lagre opphavsrettsbeskyttet materiale uten tillatelse!
Avbryt
Redigeringshjelp
(åpnes i et nytt vindu)
Denne siden er medlem av 9 skjulte kategorier:
Kategori:Artikler med døde eksterne lenker
Kategori:Artikler uten autoritetsdatalenker fra Wikidata
Kategori:Artikler uten offisielle lenker fra Wikidata
Kategori:Artikler med offisielle lenker og uten kobling til Wikidata
Kategori:1000 artikler enhver Wikipedia bør ha
Kategori:CS1-vedlikehold: Flere navn: forfatterliste
Kategori:CS1-vedlikehold: Uheldig URL
Kategori:Utmerkede artikler
Kategori:Sider med kildemaler som mangler arkivdato
Navigasjonsmeny
Personlige verktøy
Ikke logget inn
Brukerdiskusjon
Bidrag
Opprett konto
Logg inn
Navnerom
Side
Diskusjon
norsk bokmål
Visninger
Les
Rediger
Rediger kilde
Vis historikk
Mer
Søk
Navigasjon
Forside
Siste endringer
Tilfeldig side
Hjelp til MediaWiki
Spesialsider
Verktøy
Lenker hit
Relaterte endringer
Sideinformasjon
På andre prosjekter